| Peter Hogenkamp, MD | |
|
10 Commons St, Rutland, VT 05701-4651 | |
| (802) 747-3359 | |
| (802) 786-5204 |
| Full Name | Peter Hogenkamp |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 10 Commons St, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922036490 | NPI | - | NPPES |
| 0VN1657 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0420009516 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna & Hospice Of The Southwest Region Inc | Rutland, VT | Home health agency |
| Bayada Home Health Care | Williston, VT | Home health agency |
| Rutland Area Visiting Nurse Association & Hospice, | Bennington, VT | Hospice |
| Rutland Regional Medical Center | Rutland, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Drs Peter And Lisa Hogenkamp Pc | 3678675766 | 4 |
News Archive
Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced the launch of its new ProRes-S media. With the addition of ProRes-S media, Millipore's purification suite now provides a complete solution for the downstream purification of monoclonal antibodies and proteins. Developed jointly with The Dow Chemical Company, ProRes-S media offers biopharmaceutical manufacturers greater flexibility and increased throughput in a smaller manufacturing footprint.
The Wall Street Journal: "McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. health overhaul. The move is one of the clearest indications that new rules may disrupt workers' health plans as the law ripples through the real world.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.
A family of compounds found in cruciferous vegetables, such as broccoli, cauliflower, and watercress, blocked lung cancer progression in both animal studies and in tests with human lung cancer cells, report researchers from Georgetown University Medical Center and the Institute for Cancer Prevention.
› Verified 3 days ago
| Entity Name | Rutland Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578527578 PECOS PAC ID: 7214846377 Enrollment ID: O20040427000707 |
News Archive
Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced the launch of its new ProRes-S media. With the addition of ProRes-S media, Millipore's purification suite now provides a complete solution for the downstream purification of monoclonal antibodies and proteins. Developed jointly with The Dow Chemical Company, ProRes-S media offers biopharmaceutical manufacturers greater flexibility and increased throughput in a smaller manufacturing footprint.
The Wall Street Journal: "McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. health overhaul. The move is one of the clearest indications that new rules may disrupt workers' health plans as the law ripples through the real world.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.
A family of compounds found in cruciferous vegetables, such as broccoli, cauliflower, and watercress, blocked lung cancer progression in both animal studies and in tests with human lung cancer cells, report researchers from Georgetown University Medical Center and the Institute for Cancer Prevention.
› Verified 3 days ago
| Entity Name | Drs Peter And Lisa Hogenkamp Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679636765 PECOS PAC ID: 3678675766 Enrollment ID: O20070220000451 |
News Archive
Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced the launch of its new ProRes-S media. With the addition of ProRes-S media, Millipore's purification suite now provides a complete solution for the downstream purification of monoclonal antibodies and proteins. Developed jointly with The Dow Chemical Company, ProRes-S media offers biopharmaceutical manufacturers greater flexibility and increased throughput in a smaller manufacturing footprint.
The Wall Street Journal: "McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. health overhaul. The move is one of the clearest indications that new rules may disrupt workers' health plans as the law ripples through the real world.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.
A family of compounds found in cruciferous vegetables, such as broccoli, cauliflower, and watercress, blocked lung cancer progression in both animal studies and in tests with human lung cancer cells, report researchers from Georgetown University Medical Center and the Institute for Cancer Prevention.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Hogenkamp, MD 10 Commons St, Rutland, VT 05701-4651 Ph: (802) 747-3359 | Peter Hogenkamp, MD 10 Commons St, Rutland, VT 05701-4651 Ph: (802) 747-3359 |
News Archive
Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced the launch of its new ProRes-S media. With the addition of ProRes-S media, Millipore's purification suite now provides a complete solution for the downstream purification of monoclonal antibodies and proteins. Developed jointly with The Dow Chemical Company, ProRes-S media offers biopharmaceutical manufacturers greater flexibility and increased throughput in a smaller manufacturing footprint.
The Wall Street Journal: "McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. health overhaul. The move is one of the clearest indications that new rules may disrupt workers' health plans as the law ripples through the real world.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.
A family of compounds found in cruciferous vegetables, such as broccoli, cauliflower, and watercress, blocked lung cancer progression in both animal studies and in tests with human lung cancer cells, report researchers from Georgetown University Medical Center and the Institute for Cancer Prevention.
› Verified 3 days ago
Richard Carleton Baker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 Stratton Rd, Rutland, VT 05701 Phone: 802-773-3386 Fax: 802-773-4578 | |
Dr. David Benjamin Turner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 71 Allen St, Suite 403, Rutland, VT 05701 Phone: 802-772-4414 Fax: 802-772-7973 | |
Lisa Hogenkamp, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Commons St, Rutland, VT 05701 Phone: 802-747-3359 Fax: 802-786-5204 | |
Frederick Hesse, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 199 Stratton Rd Ste 1, Rutland, VT 05701 Phone: 802-775-7798 Fax: 802-775-7762 | |
Susan E Blish, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 Fax: 802-747-6260 | |
Dr. Bruce D Bullock, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Commons St, Rutland, VT 05701 Phone: 802-770-1805 Fax: 802-773-4876 | |
Dr. Megan Dawn Wright, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 |